Home › Funds › WEXFORD CAPITAL LP › TOI
WEXFORD CAPITAL LP position in TOI
STARLING ONCOLOGY INC
WEXFORD CAPITAL LP reported holding 1,711,323 shares of TOI (STARLING ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$10.8M, representing 1.42% of its reported portfolio and ranking #10 among its reported holdings. WEXFORD CAPITAL LP has disclosed TOI holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How WEXFORD CAPITAL LP's TOI position evolved
WEXFORD CAPITAL LP first disclosed a stake in TOI in Q2 2025 at 1,118,679 shares (US$2.3M). The position peaked in Q3 2026 at 1,711,323 shares, worth US$10.8M. Across 6 filings, WEXFORD CAPITAL LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,711,323 shares valued at US$10.8M. Notable position changes include a 40% increase in Q3 2025.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 1.12M | $2.29M | New |
| Q3 2025 | 1.57M | $5.48M | Add |
| Q4 2025 | 1.53M | $5.46M | Reduce |
| Q1 2026 | 1.71M | $5.25M | Add |
| Q2 2026 | 1.71M | $9.29M | Hold |
| Q3 2026 | 1.71M | $10.82M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TOI and 13F data
TOI (STARLING ONCOLOGY INC) is a company whose sector is not yet classified in our data. 68 other funds we track also report a position in TOI — the largest reported positions include JOSH ARNOLD INVESTMENT CONSULTANT, LLC (US$13.4M), BRC Group Holdings, Inc. (US$4.6M), FourWorld Capital Management LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TOI
- JOSH ARNOLD INVESTMENT CONSULTANT, LLC 2.46M sh · $13.38M · Q2 2026
- BRC Group Holdings, Inc. 722.38K sh · $4.57M · Q3 2026
- FourWorld Capital Management LLC 499.20K sh · $2.71M · Q2 2026
- Manatuck Hill Partners, LLC 450.00K sh · $2.44M · Q2 2026
- FORMULA GROWTH LTD 368.40K sh · $2.33M · Q3 2026
- Dauntless Investment Group, LLC 163.57K sh · $888.18K · Q2 2026
- Panoramic Capital, LLC 100.00K sh · $543.00K · Q2 2026
- Spark Investment Management LLC 72.80K sh · $460.10K · Q3 2026
- T3 Companies, LLC 64.50K sh · $407.64K · Q3 2026
More on WEXFORD CAPITAL LP
FAQ
How long has WEXFORD CAPITAL LP held TOI?
WEXFORD CAPITAL LP has disclosed TOI holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is WEXFORD CAPITAL LP's current position in TOI?
As of Q3 2026, WEXFORD CAPITAL LP holds 1.71M shares of TOI (STARLING ONCOLOGY INC), valued at $10.82M, representing 1.42% of its reported portfolio and ranking #10.
Has WEXFORD CAPITAL LP been buying or selling TOI?
In the latest 13F filing (Q3 2026), WEXFORD CAPITAL LP held unchanged its position in TOI. The position peaked in Q3 2026 at 1.71M shares.
Which other funds hold TOI?
Other major institutional holders of TOI include JOSH ARNOLD INVESTMENT CONSULTANT, LLC, BRC Group Holdings, Inc., FourWorld Capital Management LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.